SEARCH

SEARCH BY CITATION

References

  • 1
    Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309318; discussion 318–321.
  • 2
    Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S et al. (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade. Ann Surg 236:397406; discussion 406–407.
  • 3
    Dimick JB, Cowan JA, Jr, Knol JA, Upchurch GR, Jr. (2003) Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg 138:185191.
  • 4
    Dimick JB, Wainess RM, Cowan JA, Upchurch GR, Jr, Knol JA, Colletti LM. (2004) National trends in the use and outcomes of hepatic resection. J Am Coll Surg 199:3138.
  • 5
    de Jong MC, Mayo SC, Pulitano C, Lanella S, Ribero D, Strub J et al. (2009) Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis. J Gastrointest Surg 13:21412151.
  • 6
    de Jong MC, van Vledder MG, Ribero D, Hubert C, Gigot JF, Choti MA et al. (2010) Therapeutic efficacy of combined intraoperative ablation and resection for colorectal liver metastases: an international, multi-institutional analysis. J Gastrointest Surg 15:336344.
  • 7
    Abdalla EK, Hicks ME, Vauthey JN. (2001) Portal vein embolization: rationale, technique and future prospects. Br J Surg 88:165175.
  • 8
    Tsai S, Marques HP, de Jong MC, Mira P, Ribeiro V, Choti MA et al. (2010) Two-stage strategy for patients with extensive bilateral colorectal liver metastases. HPB 12:262269.
  • 9
    Abdalla EK, Denys A, Chevalier P, Nemr RA, Vauthey JN. (2004) Total and segmental liver volume variations: implications for liver surgery. Surgery 135:404410.
  • 10
    Nagasue N, Yukaya H. (1989) Liver resection for hepatocellular carcinoma: results from 150 consecutive patients. Cancer Chemother Pharmacol 23 (Suppl.):7882.
  • 11
    Fan ST, Lai EC, Lo CM, Ng IO, Wong J. (1995) Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg 130:198203.
  • 12
    Lai EC, Fan ST, Lo CM, Chu KM, Liu CL, Wong J. (1995) Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg 221:291298.
  • 13
    Zhou L, Rui JA, Wang SB, Chen SG, Qu Q, Chi TY et al. (2007) Outcomes and prognostic factors of cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy. World J Surg 31:17821787.
  • 14
    Nathan H, Schulick RD, Choti MA, Pawlik TM. (2009) Predictors of survival after resection of early hepatocellular carcinoma. Ann Surg 249:799805.
  • 15
    Simons JP, Ng SC, Hill JS, Shah SA, Zhou Z, Tseng JF. (2010) In-hospital mortality from liver resection for hepatocellular carcinoma: a simple risk score. Cancer 116:17331738.
  • 16
    Asiyanbola B, Chang D, Gleisner AL, Nathan H, Choti MA, Schulick RD et al. (2008) Operative mortality after hepatic resection: are literature-based rates broadly applicable? J Gastrointest Surg 12:842851.
  • 17
    Nathan H, Pawlik TM. (2008) Limitations of claims and registry data in surgical oncology research. Ann Surg Oncol 15:415423.
  • 18
    Cooper GS, Virnig B, Klabunde CN, Schussler N, Freeman J, Warren JL. (2002) Use of SEER–Medicare data for measuring cancer surgery. Med Care 40 (Suppl. 8):4348.
  • 19
    National Cancer Institute D, Surveillance Research Program, Cancer Statistics Branch. Surveillance, epidemiology, and end results (SEER) program. http://www.seer.cancer.gov. [Accessed 1 February 2010.
  • 20
    Mayo SC, Shore AD, Nathan H, Edil B, Wolfgang CL, Hirose K et al. (2010) National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis. J Gastrointest Surg 14:15781591.
  • 21
    Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. (2002) Overview of the SEER–Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40 (8 Suppl.):38.
  • 22
    Fritz AG. (2000) International Classification of Diseases for Oncology: ICD-O, 3rd edn. Geneva: World Health Organization.
  • 23
    Becker NS, Richardson P, Abraham NS, Anaya DA. (2010) Identification of patients with colorectal liver metastases using administrative databases. Abstracts of the Fifth Annual Academic Surgical Congress of the Association for Academic Surgery and Society of University Surgeons. San Antonio, TX, USA. 3–5 February 2010. J Surg Res 158:171424.
  • 24
    Potosky AL, Warren JL, Riedel ER, Klabunde CN, Earle CC, Begg CB. (2002) Measuring complications of cancer treatment using the SEER–Medicare data. Med Care 40 (8 Suppl.):6268.
  • 25
    Elixhauser A, Steiner C, Harris DR, Coffey RM. (1998) Comorbidity measures for use with administrative data. Med Care 36:827.
  • 26
    Baldwin LM, Klabunde CN, Green P, Barlow W, Wright G. (2006) In search of the perfect comorbidity measure for use with administrative claims data: does it exist? Med Care 44:745753.
  • 27
    Li B, Evans D, Faris P, Dean S, Quan H. (2008) Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases. BMC Health Serv Res 8:12.
  • 28
    Quan H, Parsons GA, Ghali WA. (2002) Validity of information on comorbidity derived from ICD-9-CCM administrative data. Med Care 40:675685.
  • 29
    Southern DA, Quan H, Ghali WA. (2004) Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data. Med Care 42:355360.
  • 30
    Kaplan EL, Meier P. (1958) Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457481.
  • 31
    Thompson HH, Tompkins RK, Longmire WP, Jr. (1983) Major hepatic resection. A 25-year experience. Ann Surg 197:375388.
  • 32
    Vauthey JN, Pawlik TM, Abdalla EK, Arens JF, Nemr RA, Wei SH et al. (2004) Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 239:722730; discussion 730–732.
  • 33
    de Jong MC, Mayo SC, Pulitano C, Lanella S, Ribero D, Strub J et al. (2009) Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis. J Gastrointest Surg 13:21412151.
  • 34
    Kishi Y, Abdalla EK, Chun YS, Zorzi D, Madoff DC, Wallace MJ et al. (2009) Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg 250:540548.
  • 35
    Gold JS, Are C, Kornprat P, Jarnagin WR, Gonen M, Fong Y et al. (2008) Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients. Ann Surg 247:109117.
  • 36
    Fortner JG, Lincer RM. (1990) Hepatic resection in the elderly. Ann Surg 211:141145.
  • 37
    Nagasue N, Kohno H, Chang YC, Taniura H, Yamanoi A, Uchida M et al. (1993) Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg 217:375384.
  • 38
    Carroll JE, Smith JK, Simons JP, Murphy MM, Ng SC, Shah SA et al. (2010) Redefining mortality after pancreatic cancer resection. J Gastrointest Surg 14:17011708.
  • 39
    Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O. (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191:3846.
  • 40
    Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD et al. (2002) Trends in longterm survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759766.
  • 41
    Imamura H, Seyama Y, Kokudo N, Aoki T, Sano K, Minagawa M et al. (2004) Single and multiple resections of multiple hepatic metastases of colorectal origin. Surgery 135:508517.
  • 42
    Kanematsu T, Furui J, Yanaga K, Okudaira S, Shimada M, Shirabe K. (2002) A 16-year experience in performing hepatic resection in 303 patients with hepatocellular carcinoma: 1985–2000. Surgery 131 (1 Suppl.):153158.
  • 43
    Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugawara Y et al. (1999) No-mortality liver resection for hepatocellular carcinoma in cirrhotic and non-cirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 134:984992.
  • 44
    Dickersin K, Min YI. (1993) Publication bias: the problem that won't go away. Ann N Y Acad Sci 703:135146; discussion 146–148.
  • 45
    Dickersin K, Chan S, Chalmers TC, Sacks HS, Smith H, Jr. (1987) Publication bias and clinical trials. Control Clin Trials 8:343353.
  • 46
    Cho SW, Steel J, Tsung A, Marsh JW, Geller DA, Gamblin TC. (2011) Safety of liver resection in the elderly: how important is age? Ann Surg Oncol 18:10881095.
  • 47
    Roland M. (2004) Linking physicians' pay to the quality of care – a major experiment in the United Kingdom. N Engl J Med 351:14481454.